Cargando…

Efficacy and Safety of Dextroamphetamine Transdermal System for the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Results from a Pivotal Phase 2 Study

OBJECTIVES: To assess efficacy and safety of the new Dextroamphetamine Transdermal System (d-ATS) to treat children and adolescents (aged 6–17 years) with attention-deficit/hyperactivity disorder (ADHD). METHODS: In this phase 2, randomized, placebo-controlled study, 4 d-ATS patches of differing dos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cutler, Andrew J., Suzuki, Katsumi, Starling, Brittney, Balakrishnan, Kanan, Komaroff, Marina, Castelli, Mariacristina, Meeves, Suzanne, Childress, Ann C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc., publishers 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972004/ https://www.ncbi.nlm.nih.gov/pubmed/35020462 http://dx.doi.org/10.1089/cap.2021.0107

Ejemplares similares

d-Amphetamine Transdermal System in Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: Secondary Endpoint Results and Post Hoc Effect Size Analyses from a Pivotal Trial
por: Cutler, Andrew J., et al.
Publicado: (2023)

Pharmacokinetic Profile of the Asenapine Transdermal System (HP-3070)
por: Suzuki, Katsumi, et al.
Publicado: (2021)

Serdexmethylphenidate/dexmethylphenidate effects on sleep in children with attention-deficit/hyperactivity disorder
por: Mattingly, Greg W., et al.
Publicado: (2023)

Gender Effects in the Efficacy of Racemic Amphetamine Sulfate in Children with Attention-Deficit/Hyperactivity Disorder
por: Childress, Ann C., et al.
Publicado: (2019)

Transdermal Therapy for Attention-Deficit Hyperactivity Disorder with the Methylphenidate Patch (MTS)
por: Findling, Robert L., et al.
Publicado: (2014)

Methylphenidate Transdermal System in Attention-Deficit Hyperactivity Disorder in Adolescentsy: Profile Report
por: Keating, Gillian M.
Publicado: (2012)

Analysis of Growth Velocity in Children with Attention-Deficit/Hyperactivity Disorder Treated for up to 12 Months with Serdexmethylphenidate/Dexmethylphenidate
por: Childress, Ann C., et al.
Publicado: (2023)

Dextroamphetamine Treatment for Children With Hypothalamic Obesity
por: van Schaik, Jiska, et al.
Publicado: (2021)

Dextroamphetamine Treatment in Children With Hypothalamic Obesity
por: van Schaik, Jiska, et al.
Publicado: (2022)

Analysis of individual items on the attention-deficit/hyperactivity disorder symptom rating scale in children and adults: the effects of age and sex in pivotal trials of lisdexamfetamine dimesylate
por: Weisler, Richard H, et al.
Publicado: (2013)

Lisdexamfetamine Dimesylate for Preschool Children with Attention-Deficit/Hyperactivity Disorder
por: Childress, Ann C., et al.
Publicado: (2020)

Safety and Tolerability of Serdexmethylphenidate/Dexmethylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder: A 12-Month, Open-Label Safety Study
por: Childress, Ann C., et al.
Publicado: (2023)

Dextroamphetamine-Amphetamine Augmentation in the Treatment of Treatment-Resistant Depression
por: Small, Tyler M, et al.
Publicado: (2022)

Efficacy, Safety, and Tolerability of an Extended-Release Orally Disintegrating Methylphenidate Tablet in Children 6–12 Years of Age with Attention-Deficit/Hyperactivity Disorder in the Laboratory Classroom Setting
por: Childress, Ann C., et al.
Publicado: (2017)

Efficacy and Safety of Multilayer, Extended-Release Methylphenidate (PRC-063) in Children 6–12 Years of Age with Attention-Deficit/Hyperactivity Disorder: A Laboratory Classroom Study
por: Childress, Ann C., et al.
Publicado: (2020)

Reasons for treatment changes in adults with attention-deficit/hyperactivity disorder: a chart review study
por: Schein, Jeff, et al.
Publicado: (2022)

Management of attention-deficit hyperactivity disorder
por: Verma, Rohit, et al.
Publicado: (2011)

The history of attention deficit hyperactivity disorder
por: Lange, Klaus W., et al.
Publicado: (2010)

Stigma in attention deficit hyperactivity disorder
por: Mueller, Anna K., et al.
Publicado: (2012)

Attention Deficit Hyperactivity Disorder and Athletes
por: White, Russell D., et al.
Publicado: (2014)

Driving and attention deficit hyperactivity disorder
por: Fuermaier, Anselm B. M., et al.
Publicado: (2015)

Genetics of attention deficit hyperactivity disorder
por: Faraone, Stephen V., et al.
Publicado: (2018)

Neuroimaging in attention-deficit/hyperactivity disorder
por: Pereira-Sanchez, Victor, et al.
Publicado: (2021)

Attention-deficit/hyperactive disorder updates
por: Kessi, Miriam, et al.
Publicado: (2022)

Reasons for Treatment Changes in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Chart Review Study
por: Schein, Jeff, et al.
Publicado: (2022)

Efficacy and Safety of Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder
por: Childress, Ann C., et al.
Publicado: (2018)

Learning efficacy of explicit visuomotor sequences in children with attention-deficit/hyperactivity disorder and Asperger syndrome
por: Watanabe, Katsumi, et al.
Publicado: (2010)

Attention deficit hyperactivity disorder (ADHD) & COVID-19: Attention deficit hyperactivity disorder: Consequences of the 1st wave
por: Insa, I., et al.
Publicado: (2021)

A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder
por: Wigal, Sharon B, et al.
Publicado: (2009)

Cancellation of outpatient appointments in patients with attention-deficit/hyperactivity disorder
por: Nomura, Kensuke, et al.
Publicado: (2021)

The role of placebo response in the efficacy outcome assessment in viloxazine extended‐release pivotal trials in paediatric subjects with attention‐deficit/hyperactivity disorder
por: Nasser, Azmi, et al.
Publicado: (2022)

Authors’ Reply to Singh and Balasundaram: Comment on “A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder”
por: Nasser, Azmi, et al.
Publicado: (2022)

Training of attention functions in children with attention deficit hyperactivity disorder
por: Tucha, Oliver, et al.
Publicado: (2011)

Connectivity supporting attention in children with attention deficit hyperactivity disorder
por: Barber, Anita D., et al.
Publicado: (2014)

Attention Patterns in Children with Attention Deficit Disorder with or without Hyperactivity
por: Zalsman, Gil, et al.
Publicado: (2003)

Neurophysiological Correlates of Attentional Fluctuation in Attention-Deficit/Hyperactivity Disorder
por: Cheung, Celeste H. M., et al.
Publicado: (2017)

Efficacy and Safety of a Chewable Methylphenidate Extended-Release Tablet in Children with Attention-Deficit/Hyperactivity Disorder
por: Wigal, Sharon B., et al.
Publicado: (2017)

Treatment of adults with attention-deficit/hyperactivity disorder
por: Kolar, Dusan, et al.
Publicado: (2008)

Treatment of adults with attention-deficit/hyperactivity disorder
por: Kolar, Dusan, et al.
Publicado: (2008)

Animal models of attention-deficit hyperactivity disorder
por: Russell, Vivienne A, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_72gck54me960ldasq1016tcfou